These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25765112)

  • 1. MicroRNA and pediatric tumors: Future perspectives.
    Gulino R; Forte S; Parenti R; Memeo L; Gulisano M
    Acta Histochem; 2015; 117(4-5):339-54. PubMed ID: 25765112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MicroRNAs as potential noninvasive markers in the diagnosis of urological malignancies].
    Gilyazova IR; Klimentova EA; Pavlov VN; Khusnutdinova EK
    Urologiia; 2016 Apr; (2):96-102. PubMed ID: 28247670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.
    Cho WC
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1273-81. PubMed ID: 20026422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors.
    Geisler L; Mohr R; Lambrecht J; Knorr J; Jann H; Loosen SH; Özdirik B; Luedde T; Hammerich L; Tacke F; Wree A; Hellberg T; Roderburg C
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of microRNAs in tumor interstitial fluid of breast tumors - a novel resource to identify biomarkers for prognostic classification and detection of cancer.
    Halvorsen AR; Helland Å; Gromov P; Wielenga VT; Talman MM; Brunner N; Sandhu V; Børresen-Dale AL; Gromova I; Haakensen VD
    Mol Oncol; 2017 Feb; 11(2):220-234. PubMed ID: 28145100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.
    Iorio MV; Casalini P; Tagliabue E; Ménard S; Croce CM
    Eur J Cancer; 2008 Dec; 44(18):2753-9. PubMed ID: 19022662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs and other small silencing RNAs in cancer.
    Rovira C; Güida MC; Cayota A
    IUBMB Life; 2010 Dec; 62(12):859-68. PubMed ID: 21154820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA, a novel marker for cancer determination (Review).
    Su Y; Zhong G; Jiang N; Huang M; Lin T
    Int J Mol Med; 2018 Oct; 42(4):1786-1798. PubMed ID: 30066837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression and function in cancer.
    Garzon R; Fabbri M; Cimmino A; Calin GA; Croce CM
    Trends Mol Med; 2006 Dec; 12(12):580-7. PubMed ID: 17071139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
    Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
    Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry as potential diagnostic pitfall in the most common solid tumors of children and adolescents.
    Magro G; Longo FR; Angelico G; Spadola S; Amore FF; Salvatorelli L
    Acta Histochem; 2015; 117(4-5):397-414. PubMed ID: 25881477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-205 in cancer: an angel or a devil?
    Qin AY; Zhang XW; Liu L; Yu JP; Li H; Wang SZ; Ren XB; Cao S
    Eur J Cell Biol; 2013 Feb; 92(2):54-60. PubMed ID: 23279926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of microRNAs for cancer diagnostics, prognostication and therapy.
    Garzon R; Marcucci G
    Curr Opin Oncol; 2012 Nov; 24(6):655-9. PubMed ID: 23079782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-21: Mechanisms of Oncogenesis and its Application in Diagnosis and Prognosis of Gastric Cancer.
    Karimi Kurdistani Z; Saberi S; Tsai KW; Mohammadi M
    Arch Iran Med; 2015 Aug; 18(8):524-36. PubMed ID: 26265521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of microRNAs in silico and in vivo: diagnostic and therapeutic applications in cancer.
    Waldman SA; Terzic A
    FEBS J; 2009 Apr; 276(8):2157-64. PubMed ID: 19250312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous microRNA levels as diagnostic biomarkers for vitreoretinal lymphoma.
    Kakkassery V; Schroers R; Coupland SE; Wunderlich MI; Schargus M; Heinz C; Wasmuth S; Heiligenhaus A; Ahle G; Lenoble P; Schlegel U; Schmiegel W; Dick HB; Baraniskin A
    Blood; 2017 Jun; 129(23):3130-3133. PubMed ID: 28389463
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered RNA turnover in carcinogenesis. The diagnostic potential of modified base excretion.
    Marvel CC; Del Rowe J; Bremer EG; Moskal JR
    Mol Chem Neuropathol; 1994; 21(2-3):353-68. PubMed ID: 7522008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNAs as biomarkers and therapeutic targets in cancer.
    Heneghan HM; Miller N; Kerin MJ
    Curr Opin Pharmacol; 2010 Oct; 10(5):543-50. PubMed ID: 20541466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
    Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
    Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond microRNA--novel RNAs derived from small non-coding RNA and their implication in cancer.
    Martens-Uzunova ES; Olvedy M; Jenster G
    Cancer Lett; 2013 Nov; 340(2):201-11. PubMed ID: 23376637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.